AN ASSAY METHOD USING INTERNAL CALIBRATION TO MEASURE THE AMOUNT OF ANALYTE IN A SAMPLE

Abstract: A method of determining the amount of test analyte in a sample using internal calibration comprises: (a) mixing a sample with a predetermined amount of a calibrator analyte foreign to the sample and with a comparable behaviour in an assay to that of the test analyte; (b) contacting the mixture (a) with a solid support containing, each in a separate area, a reagent for binding the test and calibrator analytes, respectively; (c) contacting the solid support with a mixture of labelled reagents for binding the test and calibrator analytes, respectively, and (d) determining the amount of test analyte in the sample by comparing the levels of labelled reagent bound to the test and calibrator analytes.

Description: AN ASSAY METHOD USING INTERNAL CALIBRATION TO MEASURE THE AMOUNT OF ANALYTE IN A SAMPLE FIELD OF INVENTION The present invention relates to a method for determining the amount of a test analyte in a sample using internal calibra¬ tion, as well as to a test kit for use in the method. BACKGROUND OF THE INVENTION Quantitative assays involving the binding of a given test analyte in a sample to a reagent present on a solid support make use of calibrators with which the samples tested in the assays are compared. In some assay systems, such as the radio- immunoassay (RIA) or enzyme-labelled immunosorbent assay (ELISA) , where analyses of many samples are conducted simulta¬ neously, it is ususal and convenient to include appropriate calibrators. However, when analyses are made of one sample at a time, which is typical of "doctor's office" assays, the inclusion of a set of calibrators for each sample will make the test more difficult and expensive to carry out. The results from the assays of such samples are therefore most often compared to the results obtained with a set of previously generated calibrators which is used over and over again. Such externally calibrated assays cannot take account of vari¬ ations in assay parameters such as incubation time, the temperature at which the assay is conducted, the liquid volumes of the sample and reagents and the concentration of reagents. In an attempt to remedy the drawbacks inherent in using exter¬ nal calibration in an assay, EP 253 464 discloses a method of providing internal calibration in an assay in which a receptor for an analyte in a sample and a receptor for a conjugate of an analyte receptor with a label substance are immobilized in two separate areas on a solid support. The solid support is contacted with a sample containing the analyte to bind any analyte in the sample to the analyte receptor, after which the solid support is contacted with the conjugate which binds to the analyte in the sample as well as to the receptor for the conjugate. Although the internal calibration provided in this assay takes several of the possible variations influencing signal develop¬ ment into account, the assay still has to be performed careful¬ ly with respect to the volume of the sample added, which means that the system remains relatively sensitive to outside influ¬ ence. Thus, if a double volume of the sample is erroneously added, the concentration of analyte determined for the sample will be the double of the actual concentration. The object of the present invention is to provide an assay method based on internal calibration for determining the concentration of a test analyte in a sample, which method does not show variations with respect to the above-mentioned critical parameter. SUMMARY OF THE INVENTION The present invention is based on the observation that assays for different analytes may be adjusted to progress in sub¬ stantially the same manner, resulting in calibration curves for different assays which are comparable in that they tend to be parallel. This means that a calibration curve for one analyte assay may be used to calibrate another analyte assay provided that the conversion factor between the two calibration curves obtained in the two assays is known. Accordingly, the present invention relates to a method of determining the amount of a test analyte in a sample, the method comprising (a) mixing a sample of a known volume with a predetermined amount of a calibrator analyte which is foreign to the sample in question, and which is so selected that its behaviour in an assay is comparable to that of the test analyte under the same assay conditions, (b) contacting the mixture prepared in step (a) with a solid support to which is bound, in a first discrete area, a reagent capable of selectively binding the test analyte and, in a second discrete area, a reagent capable of selectively binding the calibrator analyte, (c) subsequently contacting the solid support with a mixture of a labelled reagent capable of selectively binding the test analyte and a similarly labelled reagent capable of selectively binding the calibrator analyte, and (d) determining the amount of test analyte in the sample by comparing the levels of labelled reagent bound to the test and calibrator analytes, respectively. In another aspect, the present invention relates to a test kit for determining the amount of a test analyte in a sample, comprising, in separate containers, (a) a predetermined amount of a calibrator analyte which is foreign to the sample in question, (b) a solid support to which is bound, in a first discrete area, a reagent capable of selectively binding the test analyte and, in a second discrete area, a reagent capable of selec¬ tively binding the calibrator analyte, (c) a labelled reagent capable of selectively binding the test analyte, and (d) a similarly labelled reagent capable of selectively binding the calibrator analyte, the labelled reagents (σ) and (d) being optionally provided as a mixture thereof in a single container. In the present context, the term "test analyte" is intended to indicate a substance the concentration of which in the sample is to be measured; the test analyte is a substance for which a specific receptor exists. The term "calibrator analyte" is intended to indicate a substance used to calibrate the test analyte assay; it is also a substance for which a specific receptor exists (distinct from the receptor for the test ana¬ lyte) . A "receptor" may, for the present purpose, be defined as a substance which is able to recognize and bind to a distinc¬ tive structure on an analyte; thus, the reagents used in steps (b) and (c) of the method of the invention may be defined as receptors for the test and calibrator analytes, respectively. By mixing the predetermined amount of calibrator analyte with the sample rather than adding it in a subsequent step as in the assay described in EP 253 464, identical assay conditions are ensured for the test and calibrator analytes from the outset. The initial mixing permits the use of larger sample volumes which, in turn, makes it easier to adjust the assay system to the correct ratio of calibrator analyte to sample so that no allowances will have to be made for this ratio in subsequent steps of the assay. Thus, when withdrawing a test volume from the mixture of sample and calibrator in step (b) of the present method, it will not have to be accurately measured. As the calibrator analyte is one which is not found naturally in the sample to be analysed, the response obtained in the calibrator analyte assay will be derived from the added amount of calibra¬ tor analyte alone, thereby avoiding erroneous results. The term "comparable" is intended to mean that a calculable correspondence exists between the calibration curves of the test analyte and calibrator analyte assays, respectively, produced under similar reaction conditions. The correspondence is obtained by selecting suitable reagents (e.g. antibodies with suitable affinities) , varying the composition of the reagents and adjusting their concentration, in a manner known to a person skilled in the art. When, for carrying out step (c) of the method of the invention, a mixture of the labelled reagents is prepared, this is done to make the measurement of the analyte in the assay independent of variations in step (c) , e.g. variations in the relative amounts of labelled reagents, incubation time and temperature. The label substance used to label the reagents may be defined as a substance which either in itself or by being reacted with another compound (such as a substrate) is capable of generating a detectable signal. In the known assay using internal calibration, the calibrating system consists of a calibrator receptor which is able to bind the analyte receptor conjugate (EP 253 464) . At larger sample volumes, a larger amount of test analyte will be bound to the analyte receptor. However, since the same amount of conjugate will be bound to the calibrator receptor, this will erroneusly appear in the assay as an increased concentration of the analyte. The assay of the present invention is less sensitive to a variety of parameters such as reaction time, liquid volumes of sample and reagents and temperature so that less accuracy is required to carry out the assay. This makes the assay particu¬ larly suitable for doctor's office tests. In particular, it has been found that, unlike the previously known internal calibra- tion assays, the present way of calibrating the assay permits correction for test volume which is a critical factor for obtaining accurate determination results. DETAILED DESCRIPTION OF THE INVENTION The method of the invention is suitable for quantitating test analytes of biological origin (i.e. produced by living or¬ ganisms). Examples of such test analytes are hormones, e.g. insulin, growth hormone, chorionic gonadotropin, luteinising hormone, follicle stimulating hormone, steroid hormones; pancreatic amylase; heart structural proteins; C-reactive protein; α-foetoprotein; creatine kinase type MB or MM; blood components, e.g. blood coagulation factors such as Factor VII, Factor VIII, Factor IX, Factor X or Factor XIII, or proteolytic enzymes or precursors thereof such as thrombin, prothro bin, plasmin, plasminogen or tissue plasminogen activator; growth factors, e.g. insulin-like growth factor, platelet-derived growth factor, epidermal growth factor, colony stimulating fac- tor, transforming growth factor or fibroblast growth factor; microbial components such as bacterial or viral surface proteins or toxins, e.g. cholera toxin, diphtheria toxin. Salmonella toxin, Shiga toxin, Clostridium botulinum toxin, aflatoxin, endotoxin or Chlamvdia-specific antigen (e.g. LPS) ; or antibodies (e.g. antibodies raised in the human or animal body against pathogens) . Particularly preferred test analytes to be quantitated accor¬ ding to the method of the invention are creatine kinase type MB or MM, pancreatic amylase, heart structural proteins, c- reactive protein, α-foetoprotein or Chlamvdia-specific antigen. The sample may be any fluid containing a dissolved or dispersed material of biological origin. Thus, the sample may be selected from a body fluid, e.g. blood, serum, plasma, amniotic fluid, sputum, urine, cerebrospinal fluid, lymph, tear fluid, faeces or gastric fluid, a tissue extract, a culture medium in which a cell has been grown or a foodstuff (to test for the presence of contaminants such as pathogens or their toxins therein) . If the sample is not in itself sufficiently fluid for the present purpose, it may be admixed with a suitable fluid to the desired fluidity, for instance by ho ogenization. The calibrator analyte should be one which is not found naturally in the sample in question, and the calibrator analyte assay should exhibit a calibration curve which is comparable to the calibration curve for the test analyte assay produced under the same reaction conditions. The calibrator analyte should furthermore be stable, in particular storage stable. Examples of suitable calibrator analytes are proteins which do not cross-react with the test analyte, e.g. animal (including mammalian, bird or fish) or plant proteins, synthetic polypep- tides, haptens bound to macromolecular compounds, polysacchari- des or antibodies. The reagent capable of selectively binding the test analyte and calibrator analyte, respectively, (in the following termed "catching" reagent) may be an antibody reactive with the test or calibrator analyte, a cell surface receptor or a ligand- binding part thereof, a lectin, an antigen or an anti-idiotype antibody. The antibody used as the catching reagent is preferably a monoclonal antibody or a fragment thereof such as a F(ab') 2 or Fab' fragment, e.g. prepared as described in A. Johnstone and R. Thorpe, Immunochemistry in Practice. 2nd Ed., Blackwell Scientific Publications, 1987, pp. 35-43. The antibody may also be a polyclonal antibody or a fragment thereof, e.g. prepared as described in A. Johnstone and R. Thorpe, op. cit.. pp. 30-34 and 48-55. The cell surface receptor used as the catching reagent in the method of the invention may be a glycoprotein or glycolipid receptor. Examples of suitable glycoprotein receptors (subject, of course, to the test analyte to be measured) are hormone or growth factor receptors, e.g. the insulin, insulin-like growth factor, epidermal growth factor, platelet-derived growth factor, transforming growth factor or colony stimulating factor receptors. A ligand-binding part of the receptor is suitably the extracellular domain of a glycoprotein receptor or a ligand-binding fragment thereof. The glycolipid receptor may be one which is capable of binding viral or bacterial surface peptides or proteins. A lectin may be employed as the catching reagent in the method and test kit of the invention in cases where the test analyte comprises an appropriate carbohydrate moiety for which the lectin has affinity. Lectins are typically of plant origin and may, for instance, be lentil lectin, wheat germ lectin, peanut lectin, soybean lectin and concanavalin A. When the test and calibrator analytes are both antibodies, the catching reagent may conveniently be a natural or synthetic antigen or an anti-idiotype antibody. The anti-idiotype antibody may be a monoclonal or polyclonal antibody or a fragment thereof, and may be prepared as indicated above. The catching reagent may be immobilized directly on the solid support by physical adsorption or be bound covalently or through bridging molecules such as protein A, polylysine or an antibody (not reactive with the test or calibrator analyte, but reactive with the catching reagent) to the solid support. The solid support employed in the method and test kit of the inven¬ tion preferably comprises a polymer. The polymer may be selected from the group consisting of a plastic (e.g. latex, a polystyrene, polyvinylchloride, polyurethane, polyacrylamide, polyvinylalcohol, nylon, polyvinylacetate, and any suitable copolymer thereof) , cellulose (e.g. various types of paper, such as nitrocellulose paper and the like) , a silicon polymer (e.g. siloxane) , a polysaccharide (e.g. agarose or dextran) , or an ion exchange resin (e.g. conventional anion or cation exchange resins) . The physical shape of the solid support is not critical, although some shapes may be more convenient than others for the present purpose. Thus, the solid support may be in the shape of a plate, e.g. a microtiter plate, or a paper strip, dipstick, membrane (e.g. a nylon membrane or a cellulose filter) or solid particles (e.g. latex beads) . In a favoured embodiment of the method and test kit of the invention, the solid support further comprises, in a third discrete area, a bound antibody which does not react with either the test or calibrator analyte. The purpose of including such a reagent is to control for background in the assay caused by heterophilic antibodies or non-specific binding, e.g. hydrophobic binding, of one or more sample components to the solid support. Similarly to the catching reagent, the labelled reagent used in step (c) of the method of the invention may be an antibody reactive with the test or calibrator analyte, respectively, a cell surface receptor or a ligand-binding part thereof, a lectin, an antigen or an anti-idiotype antibody. Although it is possible to use different reagents in step (b) and (c) of the method of the invention, it is generally preferred to use the same reagent as the catching reagent and as the labelled reagent. The label substance for the reagents used for binding to the test and calibrator analytes, respectively, is preferably selected from the group consisting of enzymes, coloured or fluorescent substances and radioactive isotopes. Examples of enzymes useful as label substances are peroxidases (such as horseradish peroxidase) , phosphatases (such as acid or alkaline phosphatase) , β-galactosidase, urease, glucose oxidase, carbonic anhydrase, acetylcholinesterase, glucoamyla- se, lysozyme, malate dehydrogenase, glucose-6-phosphate dehydrogenase, β-glucosidase, proteases, pyruvate decarboxyla- se, esterases, luciferase, etc. Enzymes are not in themselves detectable but must be combined with a substrate to catalyse a reaction the end product of which is detectable. Thus, a substrate may be added after step (c) of the present method resulting in the formation of a coloured or fluorescent substance. Examples of substrates which may be employed according to the invention include hydrogen peroxide/tetramethylbenzidine or chloronaphthole or o-phenyle- nediamine or 3-(p-hydroxyphenyl) propionic acid or luminol, indoxyl phosphate, p-nitrophenylphosphate, nitrophenyl galac- topyranoside, 4-methyl umbelliferyl-D-galactopyranoside, or luciferin. Alternatively, the label substance may comprise coloured or fluorescent substances, including gold particles, coloured or fluorescent latex particles, dye particles, fluorescein, phycoerythrin or phycocyanin. Radioactive isotopes which may be used for the present purpose may be selected from 1-125, 1-131, H-3, P-35 and C-14. In a particular embodiment of the test kit of the invention for use when two or more test analytes are to be quantitated simul¬ taneously, the solid support is provided with a multiplicity of reagents for binding to different test analytes in discrete areas separate from each other as well as separate from the reagent for binding the calibrator analyte. This approach requires selection of a calibrator analyte exhibiting a standard curve which is comparable to those of the different test analytes to be determined. The test kit for use in this embodiment of the present method also comprises a multiplicity of labelled reagents, one for each test analyte. DESCRIPTION OF PREFERRED EMBODIMENTS In a currently preferred embodiment of the method of the present invention, (a) a known volume of sample suspected of containing the test analyte is mixed with a predetermined amount of bovine aproti- nin as the calibrator analyte, (b) the mixture of step (a) is poured onto a membrane to which is bound, in a first discrete area, an antibody capable of selectively binding the test analyte and, in a second discrete area, an anti-aprotinin antibody, (c) a mixture of an enzyme-labelled antibody capable of selec¬ tively binding the test analyte and an enzyme-labelled anti- aprotinin antibody is poured onto the membrane in a manner ensuring an even distribution thereof over the membrane surface, and (d) determining the amount of test analyte in the sample by comparing the signal generated by enzyme-labelled antibody bound to the test analyte and to the aprotinin, respectively. Hence, the preferred test kit to be employed in this embodiment is one wherein the calibrator analyte is aprotinin, the solid support is a membrane, the reagent capable of selectively binding the test analyte is an antibody reactive with the test analyte, the reagent capable of selectively binding the calibrator analyte is an anti-aprotinin antibody, and the label for each reagent is an enzyme. In this embodiment of the present method, the mixture of the sample and aprotinin is preferably removed from the membrane subsequent to step (b) . Furthermore, the mixture of enzyme- labelled antibodies is preferably removed from the membrane subsequent to step (c) . Such removal may for instance be carried out by suction for which purpose the membrane may act as a filter. As such, it may suitably be a nylon-based membrane placed on a suction funnel. The invention is further illustrated in the following examples 5 which are not in any way intended to limit the scope of the invention as claimed. EXAMPLE 1 Assay for CK-MB using myoglobin as the calibrator analyte A microporous membrane preactivated for covalently coup-ling of 0 proteins (Pall Immunodyne immunoaffinity membrane) was placed in a Biodot microfiltration apparatus (available from BioRad) and coated with a monoclonal antibody reacting against human creatine kinase B subunit (available from Novo Nordisk A/S) in one well and with a monoclonal antibody reactive with human 5 myoglobin (available from Novo Nordisk A/S) in another well. Coating buffer without antibody was added to a third well as a control. The membrane was then blocked with a 0.2% casein solution in phosphate buffered saline (PBS), pH 7.2. Human myoglobin was added to a bovine serum sample containing 0 human creative kinase M and B subunit (available from Novo Nordisk A/S) (CK-MB) . 50 μl of this mixture was added to each well folloved by 50 μl of a mixture of horseradish peroxidase (HRP)-conjugated monoclonal anti-human creatine kinase M subunit (available from Novo Nordisk A/S) and HRP-conjugated 25 monoclonal anti-human myoglobin (available from Novo Nordisk A/S) . These HRP- conjugated monoclonal antibodies were selected so as to be reactive with the analytes bound to the immobilized antibodies. One minute after addition of the conjugate mixture, the membrane was washed with 3 x 300 μl PBS, pH 7.2, containing 300.05% Tween 20 and 0.25 M (NH 4 ) 2 S0 4 . 50 μl of a substrate solution containing hydrogen peroxide and tetramethylbenzidine was then added, and after 3 min the reaction was stopped by washing the membrane with distilled water containing 0.01% Na- azide. A positive sample resulted in a blue spot. Finally, the response was read by means of a reflectometer (available from Shi adzu) and the measured reflectance was transformed accor- ding to the Kubelka-Munk equation to the entity K/S. The myoglobin assay was adjusted through the concentration and composition of the reactants to give a calibration curve parallel to the CK-MB calibration curve. The myoglobin calibra¬ tor was then assigned CK-MB values by comparing the calibration curves for the two assays. An assigned CK-MB concentration value of the myoglobin calibrator means that quantitatively it elicits the same response in the myoglobin assay as the equivalent concentration of CK-MB in the creatine kinase assay. The myoglobin calibrator used in the examples had an assigned CK-MB value of 25 ng/ml. Furthermore, the control was assigned a CK-MB concentration value of 0 ng/ml. The CK-MB concentration in the sample was calculated by linear regression from the slope and intercept determined by the myoglobin analyte response and the background value. The results shown in Table 1 and Table 2 below indicate that the myoglobin-calibrated CK-MB assay was able to quantitate the CK-MB concentration in a sample and that the values of the myoglobin-calibrated assay compared well to those obtained by conventional calibration using a set of CK-MB calibrators. EXAMPLE 2 Assays were performed substantially as described in Example 1 with the exception that two parameters (sample volume and colour development time) , which are known to exert a strong influence on this type of immunoassay, were varied. It appears from Tables 3 and 4 below that variations in these parameters result in considerable variations in the measured K/S values. However, the concentration of CK-MB determined was substan¬ tially unaffected by these variations. Table 1 Quantitation of CK-MB cone. CK-MB cone* CK-MB system Background Myoglobin sys (0 ng CK-MB/ml)** (25 ng CK-MB/ ng/ml K/S K/S K/S * Bovine serum spiked with human CK-MB ** Assigned CK-MB value Table 2 Comparison CK-MB concentration ng/ml True value* Calibration Calibration with CK-MB with myoglobin system** system*** 20 19 21 * spiked with a known amount of CK-MB, the concentration verified by an assay commer¬ cially available for the quantitation of CK-MB (NovoClone EIA CK-MB) ** ' calculated using the assay described and CK-MB calib. 0, 10, 25, 50, and 100 ng/ml. Assay run in duplicate. *** From table 1 Table 3 Robustness. Variation in sample volume Myoglobin system CK-MB cone** (25 ng CK-MB/ml)* K/S ng/ml 50 Mean ± S.D. 27 ± 2 0.853 24 0.853 24 100 0.886 26 0.944 22 0.974 24 Mean ± S.D. 24 ± 1 * Assigned CK-MB value ** Calculated Table 4 Robustness. Variation colour development time Colour development CK-MB system Background Myoglobin system CK-MB cone* time (0 ng CK-MB/ml)* (25 ng CK-MB/ml)* minutes K/S K/S K/S ng/ml Mean ± S . D. 26 ± 2 0.656 31 0.797 26 0.787 26 0.880 23 0.944 24 * Assigned CK-MB value ** Calculated

Claims: CLAIMS 1. A method of determining the amount of a test analyte in a sample using internal calibration, the method comprising (a) mixing a sample of known volume with a predetermined amount of a calibrator analyte which is foreign to the sample in question, and which is so selected that its behaviour in an assay is comparable to that of the test analyte under the same assay conditions, (b) contacting the mixture prepared in step (a) with a solid support to which is bound, in a first discrete area, a reagent capable of selectively binding the test analyte and, in a sec¬ ond discrete area, a reagent capable of selectively binding the calibrator analyte, (c) subsequently contacting the solid support with a mixture of a labelled reagent capable of selectively binding the test ana¬ lyte and a similarly labelled reagent capable of selectively binding the calibrator analyte, and (d) determining the amount of test analyte in the sample by comparing the levels of labelled reagent bound to the test and calibrator analytes, respectively. 2. A method accoding to claim 1, wherein the test analyte is a hormone, e.g. insulin, growth hormone, chorionic gonadotropin, luteinising hormone, follicle stimulating hormone, a steroid hormone, pancreatic amylase, a heart structural protein, C-re- active protein, α-foetoprotein, creatine kinase type MB or MM, a bacterial or viral surface protein, a blood component, e.g. a blood coagulation factor such as Factor VII, Factor VIII, Factor IX, Factor X or Factor XIII, or a proteolytic enzyme or precursor thereof such as thrombin, prothrombin, plasmin, plas- minogen, tissue plasminogen activator, a growth factor, e.g. insulin-like growth factor, platelet-derived growth factor, epidermal growth factor, colony stimulating factor, transform¬ ing growth factor or fibroblast growth factor, a microbial component such as a toxin, e.g. cholera toxin, diphtheria toxin, Salmonella toxin, Shiga toxin, Clostridium botulinu 5 toxin, aflatoxin, endotoxin or Chlamvdia-specific antigen (e.g. LPS) , or an antibody (e.g. an antibody raised in the human or animal body against a pathogen) . 3. A method according to claim 1 or 2, wherein the calibrator analyte is an animal or plant protein which does not cross- 10 react with the test analyte, e.g. aprotinin or a synthetic polypeptide, a hapten bound to a acromolecular compound, a polysaccharide or an antibody. 4. A method according to claim 1 or 2, wherein the sample is a body fluid, e.g. blood, serum, plasma, amniotic fluid, sputum, 15 urine, cerebrospinal fluid, lymph, tear fluid, faeces or gas¬ tric fluid, a tissue extract, a culture medium in which a cell has been grown or a foodstuff. 5. A method according to any of claims 1-4, wherein the reagent capable of selectively binding the test analyte is an antibody 20 reactive with the test analyte, a cell surface receptor or a ligand-binding part thereof, a lectin, an antigen or an anti- idiotype antibody. 6. A method according to claim 5, wherein the antibody is a monoclonal or polyclonal antibody or a fragment thereof. 257. A method according to claim 5, wherein the cell surface rec¬ eptor is a glycoprotein or glycolipid receptor. 8. A method according to claim 5, wherein the lectin is selected from the group consisting of lentil lectin, wheat germ lectin, peanut lectin, soybean lectin and concanavalin A. 9. A method according to claim 5, wherein the antigen is a natural or synthetic antigen containing at least one epitope which is reactive with a test analyte antibody. 10. A method according to claim 5, wherein the anti-idiotype antibody is one which is reactive with a test analyte antibody. 11. A method according to claim 10, wherein the anti-idiotype antibody is a monoclonal or polyclonal antibody or a fragment thereof. 12. A method according to any of claims 1-4, w erein the reagent capable of selectively binding the calibrator analyte is an antibody reactive with the calibrator analyte, a cell surface receptor or a ligand-binding part thereof, an antigen, a lectin or an anti-idiotype antibody. 13. A method according to claim 12, wherein the antibody is a monoclonal or polyclonal antibody or a fragment thereof. 14. A method according to claim 12, wherein the cell surface receptor is a glycoprotein or glycolipid receptor. 15. A method according to claim 12, wherein the lectin is eg. lentil lectin, wheat germ lectin, peanut lectin, soybean lectin and concanavalin A. 16. A method according to claim 12, wherein the anti-idiotype antibody is one which is reactive with a calibrator analyte antibody. 17. A method according to claim 16, wherein the anti-idiotype antibody is a monoclonal or polyclonal antibody or a fragment thereof. 18. A method according to any of claims 1-17, wherein the solid support to which the reagents for binding the test and calib- rator analytes, respectively, are bound is in the form of a plate, e.g. a microtiter plate, a paper strip, dipstick, membrane or solid particles. 19. A method according to claim 18, wherein the solid support comprises a polymer, e.g. a plastic, polysaccharide, ion exchange resin, cellulose or silicon polymer, or a ceramic material, e.g. glass such as controlled pore glass. 20. A method according to any of claims 1-19, wherein the solid support comprises, in a third discrete area, a bound non-speci- fie reagent. 21. A method according to claim 20, wherein the non-specific reagent is an antibody which is not reactive with any component of the sample. 22. A method according to any of claims 1-21, wherein the label substance is selected from the group consisting of enzymes, coloured or fluorescent substances and radioactive isotopes. 23. A method according to any of claims 1-22, wherein (a) a known volume of a sample suspected of containing the test analyte is mixed with a predetermined amount of aprotinin as the calibrator analyte, (b) the mixture of step (a) is poured onto a membrane to which is bound, in a first discrete area, an antibody capable of se¬ lectively binding the test analyte and, in a second discrete area, an anti-aprotinin antibody, (c) a mixture of an enzyme-labelled antibody capable of selec¬ tively binding the test analyte and an enzyme-labelled anti- aprotinin antibody is poured onto the membrane, and (d) determining the amount of test analyte in the sample by comparing the signals generated by enzyme-labelled antibody bound to the test analyte and to the aprotinin, respectively. 24. A method according to claim 23, wherein the test analyte is creatine kinase type MB or MM, pancreatic amylase, heart struc¬ tural proteins, C-reactive protein, α-foetoprotein or Chlamydi- a-specific antigen (e.g. LPS) . 25. A method according to any of claims 1-24, wherein multiple reagents, each of which is able selectively to bind a test ana- lyte, are bound to the solid support in discrete areas separate from each other and separate from the discrete area in which the reagent capable of selectively binding the calibrator analyte is bound. 26. A test kit for determining the amount of a test analyte in a sample, comprising, in separate containers, (a) a predetermined amount of a calibrator analyte which is foreign to the sample in question, (b) a solid support to which is bound, in a first discrete area, a reagent capable of selectively binding the test analyte and, in a second discrete area, a reagent capable of selective¬ ly binding the calibrator analyte, (c) a labelled reagent capable of selectively binding the test analyte, and (d) a similarly labelled reagent capable of selectively binding the calibrator analyte, the labelled reagents (c) and (d) being optionally provided as a mixture thereof in a single container. 27. A test kit according to claim 26, wherein the calibrator analyte is an animal or plant protein which does not cross- react with the test analyte, e.g. aprotinin, a synthetic polypeptide, a hapten bound to a macromolecular compound, a 5 polysaccharide or an antibody. 28. A test kit according to claim 26 or 27, wherein the reagent capable of selectively binding the test analyte is an antibody reactive with the test analyte, a cell surface receptor or a ligand-binding part thereof, a lectin, an antigen or an anti- 10 idiotype antibody. 29. A test kit according to claim 28, wherein the antibody is a monoclonal or polyclonal antibody or a fragment thereof. 30. A test kit according to claim 28, wherein the cell surface receptor is a glycoprotein or glycolipid receptor. 1531. A test kit according to claim 28, wherein the lectin is selected from the group consisting of lentil lectin, wheat germ lectin, peanut lectin, soybean lectin and concanavalin A. 32. A test kit according to claim 28, wherein the antigen is a natural or synthetic antigen containing at least one epitope 20 which is reactive with a test analyte antibody. 33. A test kit according to claim 28, wherein the anti-idiotype antibody is one which is reactive with a test analyte antibody. 34. A test kit according to claim 33, wherein the anti-idiotype antibody is a monoclonal or polyclonal antibody or a fragment 25 thereof. 35. A test kit according to claim 26, wherein the reagent capable of selectively binding the calibrator analyte is an antibody reactive with the calibrator analyte, a cell surface receptor or a ligand-binding part thereof, an antigen, a lectin or an anti-antibody. 36. A test kit according to claim 35, wherein the antibody is a monoclonal or polyclonal antibody or a fragment thereof. 537. A test kit according to claim 36, wherein the cell surface receptor is a glycoprotein or glycolipid receptor. 38. A test kit according to claim 36, wherein the lectin is selected from the group consisting of lentil lectin, wheat germ lectin, peanut lectin, soybean lectin and concanavalin A. 1039. A test kit according to claim 36, wherein the anti-idiotype antibody is one which is reactive with a calibrator analyte antibody. 40. A test kit according to claim 36, wherein the anti-idiotype antibody is a monoclonal or polyclonal antibody or a fragment 15 thereof. 41. A test kit according to any of claims 26-41, wherein the solid support to which the reagents for binding the test and calibrator analytes, respectively, are bound is in the form of a plate, e.g. a microtiter plate, a paper strip, dipstick, 20 membrane or solid particles. 42. A test kit according to claim 51, wherein the solid support comprises a polymer, e.g. a plastic, polysaccharide, ion exchange resin, cellulose or silicon polymer, or a ceramic material, e.g. glass such as controlled pore glass. 2543. A test kit according to any of claims 26-42, wherein the solid support additionally comprises, in a third discrete area, a bound non-specific reagent. 44. A test kit according to claim 43, wherein the non-specific reagent is an antibody which is not reactive with any component in the sample. 45. A test kit according to any of claims 26-44, wherein the 5 label substance is selected from the group consisting of enzymes, coloured or fluorescent substances and radioactive isotopes. 46. A test kit according to any of claims 26-45, wherein the calibrator analyte is aprotinin, the solid support is a mem- 10 brane, the reagent capable of selectively binding the test ana¬ lyte is an antibody reactive with the test analyte, the reagent capable of selectively binding the calibrator analyte is an anti-aprotinin antibody, and the label for each reagent is an enzyme. 1547. A test kit according to any of claims 26-46, wherein mul¬ tiple reagents, each of which is able selectively to bind a test analyte, are bound to the solid support in discrete areas separate from each other and separate from the discrete area in which the reagent capable of selectively binding the calibrator 20 analyte is bound. 48. A test kit according to claim 47, comprising multiple labelled reagents for binding to different test analytes.

Inventors: POULSEN FRITZ, SELMER JOHAN, POULSEN, FRITZ, SELMER, JOHAN
Applicants: NOVONORDISK AS, NOVO NORDISK A/S
Application year: 1991
Main classification: G01N33
IPC codes: G01N33, G01N35